Form 4: Elanco CEO Acquires Deferred Stock Units

Elanco Animal Health CEO Jeffrey N. Simmons acquired 117.9906 deferred stock units on January 9, 2026, increasing his beneficial ownership.

Summary

• Jeffrey N. Simmons, President, CEO, and Director of Elanco Animal Health Inc. (ELAN), reported an acquisition of deferred stock units.
• On January 9, 2026, Simmons acquired 117.9906 Deferred Stock Units (DSUs).
• Each DSU represents the right to receive one share of Company common stock or the cash equivalent.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.
• The implied price per DSU was $23.47.
• Following this transaction, Simmons beneficially owns 18,845.5217 Deferred Stock Units.
• DSUs settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with the Executive Deferral and Stock Match Plan.

Sentiment

Score: 7

Explanation: The acquisition of deferred stock units by a key executive, especially as part of a pre-planned compensation structure, is generally viewed as a neutral to slightly positive signal, indicating continued alignment of management's interests with shareholders.

Positives

• An insider, the President, CEO, and Director, acquired additional deferred stock units, which can signal confidence in the company's future performance.
• The transaction was part of a pre-arranged Rule 10b5-1 plan, indicating a structured approach to compensation and equity ownership.

Future Outlook

The filing does not provide specific forward-looking statements or guidance beyond the settlement terms of the deferred stock units, which occur upon termination of employment or a specified future year.

Industry Context

This Form 4 filing is a routine disclosure of an insider's equity transaction and does not provide broader industry context or trends. It reflects an individual executive's compensation and ownership within Elanco Animal Health, a company operating in the animal health industry.

Stakeholder Impact

• Shareholders: The acquisition of additional equity by the CEO may be seen as a positive sign of management's confidence in the company's long-term prospects, aligning executive interests with shareholder value.

Next Steps

• Deferred stock units will settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with the Executive Deferral and Stock Match Plan.

Key Dates

Keywords

Elanco Animal Health, ELAN, Jeffrey N. Simmons, Deferred Stock Units, Insider Trading, Form 4, Executive Compensation, Rule 10b5-1